ERA

Download the full-sized PDF of Enhanced detection of cancer biomarkers in blood-borne extracellular vesicles using nanodroplets and focused ultrasoundDownload the full-sized PDF

Analytics

Share

Permanent link (DOI): https://doi.org/10.7939/R3QJ78B7Q

Download

Export to: EndNote  |  Zotero  |  Mendeley

Communities

This file is in the following communities:

Biological Sciences, Department of

Collections

This file is not currently in any collections.

Enhanced detection of cancer biomarkers in blood-borne extracellular vesicles using nanodroplets and focused ultrasound University of Alberta

Descriptions

Author or creator
Robert J Paproski
Juan Jovel
Gane Ka-Shu Wong
John D Lewis
Roger J Zemp
Additional contributors
Subject/Keyword
Cancer Biomarkers
nanodroplets
Type of item
Journal Article (Published)
Language
English
Place
Time
Description
The feasibility of personalized medicine approaches will be greatly improved by the development of noninvasive methods to interrogate tumor biology. Extracellular vesicles shed by solid tumors into the bloodstream have been under recent investigation as a source of tumor-derived biomarkers such as proteins and nucleic acids. We report here an approach using submicrometer perfluorobutane nanodroplets and focused ultrasound to enhance the release of extracellular vesicles from specific locations in tumors into the blood. The released extracellular vesicles were enumerated and characterized using micro flow cytometry. Only in the presence of nanodroplets could ultrasound release appreciable levels of tumor-derived vesicles into the blood. Sonication of HT1080-GFP tumors did not increase the number of circulating tumor cells or the metastatic burden in the tumor-bearing embryos. A variety of biological molecules were successfully detected in tumor-derived extracellular vesicles, including cancer-associated proteins, mRNAs, and miRNAs. Sonication of xenograft HT1080 fibrosarcoma tumors released extracellular vesicles that contained detectable RAC1 mRNA with the highly tumorigenic N92I mutation known to exist in HT1080 cells. Deep sequencing serum samples of embryos with sonicated tumors allowed the identification of an additional 13 known heterozygous mutations in HT1080 cells. Applying ultrasound to HT1080 tumors increased tumor-derived DNA in the serum by two orders of magnitude. This work is the first demonstration of enhanced extracellular vesicle release by ultrasound stimulation and suggests that nanodroplets/ultrasound offers promise for genetic profiling of tumor phenotype and aggressiveness by stimulating the release of extracellular vesicles. Cancer Res; 77(1); 3–13. ©2016 AACR.
Date created

DOI
doi:10.7939/R3QJ78B7Q
License information
Attribution 4.0 International
Rights

Citation for previous publication

Source

Link to related item

File Details

Date Uploaded
Date Modified
2017-09-07T18:28:21.120+00:00
Audit Status
Audits have not yet been run on this file.
Characterization
File format: pdf (Portable Document Format)
Mime type: application/pdf
File size: 1597655
Last modified: 2017:09:07 12:28:26-06:00
Filename: Enhanced detection of cancer biomarkers in blood-borne extracellular vesicles using nanodroplets and focused ultrasound.pdf
Original checksum: bbe0b4fd633b77f315ec74384ee6c1ee
Well formed: true
Valid: true
File title: CAN-15-3231 3..13
File author: AR PPG
Page count: 12
Activity of users you follow
User Activity Date